MBRX ▼ -1.7% - Moleculin Biotech, Inc.
$MBRX - Moleculin Announces Publication of Peer-Reviewed Cardiac Safety Analysis of Annamycin in Frontiers in Cardiovascular Medicine
28-SEP-2026 07:00 AM ET
Share this post
More filings for $MBRX
MBRX ▼ -10.8% - Moleculin Biotech, Inc.Oct 16, 2026MBRX ▼ -1.8% - Moleculin Biotech, Inc.Sep 29, 2026MBRX ▲ +14.5% - Moleculin Biotech, Inc.Sep 25, 2026MBRX ▲ +4.2% - Moleculin Biotech, Inc.Sep 14, 2026MBRX ▼ -2.4% - Moleculin Biotech, Inc.Sep 11, 2026MBRX - Moleculin Biotech, Inc. - SEC Filing Update (25-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 25, 2026
View full $MBRX filing history →💬 Comments
Loading comments…
Leave a comment